RPG Life Sciences
add_icon

RPG Life Sciences

1,900.50
-64.40
(-3.28%)
Market Cap
3,143.24 Cr
PE Ratio
16.08
Volume
6,228.00
Day High - Low
1,954.00 - 1,893.00
52W High-Low
2,725.00 - 1,764.20
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
3,143.24 Cr
EPS
110.80
PE Ratio
16.08
PB Ratio
196.41
Book Value
10.03
EBITDA
172.30
Dividend Yield
1.22 %
Industry
Healthcare
Return on Equity
34.54
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
positive
RPG Life Sciences indicates robust January performance for API segment with strong domestic portfolio showing positive momentum according to CNBC-TV18 coverage.
neutral
RPG Life Sciences reported Q3 net profit of ₹221 million, down from ₹350 million YoY, while revenue increased to ₹1.8 billion from ₹1.72 billion in the same period last year.
negative
RPG Life Sciences received GST order from Maharashtra State Tax Officer demanding ₹1.08 crores for tax period April 2021 to March 2022. Company plans to contest the demand through legal remedies.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,807.80
#1 4,33,751.78
39.98
#1 54,729.00
9.71
#1 10,980
16.07
70.29
6,102.00
1,61,988.93
67.21
9,712.00
18.67
2,191
-1.02
49.00
4,392.30
1,48,655.39
66.21
11,539.40
6.99
1,911
26.24
68.79
1,290.70
1,07,725.74
19.93
33,741.20
16.73
5,725
-15.28
59.78
1,317.00
1,06,383.55
23.61
28,409.50
7.12
5,291
-57.18
43.23
2,322.20
1,06,077.82
23.07
22,909.50
13.74
3,306
#1 37.44
67.87
907.55
91,320.77
#1 18.35
23,511.00
18.55
4,615
-0.32
52.66
2,132.30
88,022.43
50.56
12,744.20
#1 20.90
2,007
7.65
55.18
1,303.10
75,684.26
21.89
32,345.60
9.43
3,484
7.59
70.43
5,382.00
64,349.88
26.89
13,458.30
3.70
2,216
1.90
43.98

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
13.03 %
Net Income Growth
108.89 %
Cash Flow Change
-17.49 %
ROE
47.67 %
ROCE
40.14 %
EBITDA Margin (Avg.)
12.63 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
176
231
166
197
183
Expenses
124
90
125
143
149
EBITDA
53
140
41
55
35
Operating Profit %
28 %
37 %
26 %
21 %
17 %
Depreciation
6
5
5
5
5
Interest
0
0
0
0
0
Profit Before Tax
47
135
35
50
29
Tax
12
18
9
13
7
Net Profit
35
117
26
37
22
EPS in ₹
21.12
70.96
15.90
22.28
13.38

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
197
205
247
291
251
267
303
345
419
513
658
Fixed Assets
105
109
137
131
128
123
113
104
124
114
172
Current Assets
86
87
96
143
97
126
176
207
264
298
465
Capital Work in Progress
1
2
2
9
17
10
12
31
25
96
16
Investments
0
0
0
0
0
0
0
0
58
91
127
Other Assets
92
94
108
152
106
134
178
210
211
212
343
Total Equity & Liabilities
197
205
247
291
251
267
303
345
419
513
658
Current Liabilities
67
67
79
121
78
83
80
80
103
131
120
Non Current Liabilities
5
5
21
16
13
8
7
9
9
7
7
Total Equity
125
134
147
155
161
177
216
256
308
375
531
Reserve & Surplus
112
120
134
142
147
163
203
243
294
362
517
Share Capital
13
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
1
-1
0
0
40
17
-32
-5
9
Investing Activities
-10
-15
-30
-16
-19
-11
-8
-35
-106
-79
-42
Operating Activities
-2
33
7
15
46
50
58
65
91
94
78
Financing Activities
12
-18
23
0
-27
-39
-11
-14
-17
-20
-27

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
72.07 %
72.07 %
72.07 %
72.07 %
72.07 %
72.41 %
72.61 %
72.61 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.95 %
72.95 %
72.95 %
72.95 %
72.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.46 %
0.56 %
0.89 %
1.14 %
1.35 %
1.30 %
1.45 %
1.35 %
1.11 %
1.00 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
2.04 %
2.02 %
2.12 %
2.29 %
3.59 %
3.79 %
4.19 %
4.63 %
5.45 %
6.06 %
6.14 %
6.48 %
6.70 %
7.04 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.45 %
20.59 %
20.58 %
20.65 %
20.85 %
20.37 %
19.91 %
20.26 %
19.91 %
19.45 %
18.41 %
18.16 %
17.41 %
16.79 %
15.92 %
15.58 %
15.33 %
15.46 %
15.37 %
15.17 %
Others
7.47 %
7.33 %
7.34 %
7.28 %
7.07 %
7.21 %
5.44 %
5.10 %
5.16 %
5.45 %
4.73 %
4.67 %
4.70 %
4.62 %
4.47 %
4.11 %
4.12 %
3.76 %
3.88 %
3.83 %
No of Share Holders
18,701
20,564
23,674
22,768
22,821
22,115
20,757
21,360
20,837
20,226
21,088
21,866
22,137
22,232
23,481
24,891
24,867
25,832
26,657
25,905

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 2.8 2.4 2.4 4 7.2 9.6 12 16 24 0.00
Dividend Yield (%) 0.73 0.97 1.41 1.03 1.28 1.4 0.79 0.7 1.22 0.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2026
General UpdatesJan 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 27, 2026
Financial Result Quarter Ended On December 31 2025Jan 27, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On January 27 2026.Jan 27, 2026
Board Meeting Intimation for Intimation Of Board MeetingJan 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 07, 2026
Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority MaharashtraDec 29, 2025
Incorporation Of A Wholly Owned Subsidiary.Dec 24, 2025
Closure of Trading WindowDec 24, 2025
Disclosure Under Regulation 30(5)Dec 15, 2025
Intimation With Respect To Proposed Incorporation Of A Wholly Owned Subsidiary Is Enclosed HerewithDec 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 15, 2025
Outcome Of The Board Meeting Held On December 15 2025Dec 15, 2025
Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority Gujarat.Nov 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 17, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Oct 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 17, 2025
RPG Life Sciences Limited Has Submitted To The Exchange The Financial Results For The Quarter And Half Year Ended September 30 2025.Oct 17, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On October 17 2025Oct 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Board Meeting Intimation for Board Meeting Intimation For RPG Life Sciences Limited To Consider And Approve Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Oct 10, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Intimation Regarding 100 Days Campaign - "Saksham Niveshak"Aug 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 26, 2025
Amendment In Policy Of The CompanyJul 25, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 25, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 25, 2025
Unaudited Financial Result For The Quarter Ended On June 30 2025Jul 25, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On July 25 2025Jul 25, 2025
Board Meeting Intimation for Board Meeting Intimation To Consider And Approve Unaudited Financial Results For The Quarter Ended June 30 2025Jul 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Voting Result Of 18Th Annual General MeetingJul 16, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 16, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 16, 2025

Mutual Fund Holdings

Technical Indicators

RSI(14)
Neutral
52.30
ATR(14)
Volatile
63.65
STOCH(9,6)
Neutral
73.51
STOCH RSI(14)
Overbought
98.52
MACD(12,26)
Bullish
16.72
ADX(14)
Strong Trend
39.14
UO(9)
Bearish
69.67
ROC(12)
Uptrend And Accelerating
2.95
WillR(14)
Overbought
-9.10